Buy FTPP Adipotide Monaco, also known as Fat-Targeted Proapoptotic Peptide. It is designed to target and reduce fat tissue, which may aid in weight loss and improve metabolic health.
Adipotide, also known as FTPP, is a synthetic peptide that is being studied as a potential weight loss therapy. It is composed of a 28 amino acid sequence that works by targeting the blood supply to fat cells, causing these cells to die and eventually be reabsorbed by the body. This process leads to a reduction in fat tissue and may improve overall metabolic health.
Unlike traditional weight loss methods such as dieting or exercise, which focus on reducing the size of fat cells, Adipotide directly eliminates fat cells from the body. While it is still in the experimental stages, researchers believe it could one day offer a novel approach to managing obesity and related health conditions such as diabetes. It is important to note that further studies are necessary to fully understand its safety and effectiveness in humans.
Adipotide works by targeting the blood vessels that supply nutrients to fat tissues, a process known as angiogenesis inhibition. The peptide specifically binds to the prohibition receptor 1 (p100) and the αvβ3 integrin receptor, molecules involved in cellular adhesion and signalling within the blood vessels surrounding adipose tissue.
By interacting with these receptors, adipotide disrupts essential processes in these blood vessels, effectively cutting off the blood supply to fat-storing cells. Without the necessary oxygen and nutrients, these cells undergo apoptosis, a form of programmed cell death, leading to a reduction in fat deposits. This mechanism not only makes the peptide more effective but also reduces damage to other tissues. This creates a more targeted and potentially safer way to treat obesity compared to traditional methods.
Molecular Formula: C111H206N36O28S2
Molecular Weight: 2557.2 g/mol
Sequence: H-Cys-Lys-Gly-Gly-Arg-Ala-Lys-Asp-Cys-Gly-Gly-D-Lys-D-Leu-D-Ala-D-Lys-D-Leu-D-Ala-D-Lys-D-Lys-D-Leu-D-Ala-D-Lys-D-Leu-D-Ala-D-Lys-OH
View our FTPP Adipotide High-Performance Liquid Chromatography (HPLC) Certificate here.
Boosts Energy Levels: Research shows that it may have a potential role in improving energy metabolism. By targeting and reducing excess fat tissue, it helps the body use energy more efficiently. Monaco Studies suggest that less fat leads to lower inflammation and better mitochondrial function, which can boost energy levels and endurance. Additionally, it’s ability to influence metabolic pathways makes it a promising option for reducing fatigue and improving physical performance. Ongoing research is focused on understanding these effects further, opening the door to new possibilities in energy management and metabolic health [1].
One study examined how a proapoptotic peptide targeting adipose tissue vasculature affects obesity and energy balance. In mice and rats on a high-fat diet (HFD), the peptide reduced body weight by lowering food intake without impacting energy expenditure or causing illness. The rapid weight loss was independent of leptin signaling, despite decreased leptin levels. The findings highlight a new connection between adipose tissue vasculature and food intake regulation [2].
Improves Insulin Sensitivity: Recent research suggests that it could help improve insulin sensitivity and reduce insulin secretion, offering new hope for managing conditions like overt type 2 diabetes. By targeting and reducing visceral fat, closely linked to insulin resistance, the peptide helps improve the regualtion of glucose levels in the body. Studies show that reducing fat deposits also lowers inflammation, which is a key factor in disrupted insulin signaling. Additionally, its effect on mitochondrial function helps optimise energy use, supporting balanced blood sugar levels. While more clinical trials are needed to confirm its full potential, these findings indicate that it could be a useful tool in treating diabetes and other metabolic disorders [3].
Combats Obesity: It has shown potential in addressing obesity through its targeted mechanism of action. By promoting apoptosis in adipose tissue, particularly in white fat deposits, it effectively reduces fat mass without the need for invasive procedures. Monaco Studies have demonstrated that this selective targeting can lead to significant weight loss in animal models, paving the way for future applications in humans. Furthermore, the reduction in fat mass contributes to improved metabolic health by alleviating conditions such as insulin resistance and systemic inflammation, which are closely linked to obesity. These findings highlight it’s promise as a novel therapeutic approach to combat obesity and its associated health risks [4].
Non-Alcoholic Fatty Liver Disease: NAFLD is linked to excess liver fat, often tied to obesity and metabolic issues. Adipotide shows promise in treating NAFLD by reducing fat mass through targeted apoptosis in adipose tissue, decreasing liver fat, and improving liver function. Its effects, such as lowering insulin resistance and systemic inflammation, further support its potential as a treatment for NAFLD and preventing its progression to severe stages like NASH [5].
Cancer Research: It has shown significant potential in cancer research due to its ability to target and reduce adipose tissue. Many cancers, particularly those associated with obesity, thrive in environments rich in excess fat tissue, which can promote tumour growth and progression. By selectively inducing apoptosis in the blood vessels that supply fat tissue, it reduces overall fat mass, potentially disrupting the microenvironment that supports tumour development. Additionally, the reduction in adiposity has been linked to improved metabolic conditions, such as decreased systemic inflammation and insulin resistance, both of which are known to influence cancer progression. These effects suggest that it may prove to be a valuable adjuvant therapy in managing obesity-related cancers and improving patient outcomes [6].
Potential Treatment For Heart Disease: Recent research has transformed our understanding of adipose tissue, highlighting its critical role in cardiovascular health. Adipose tissue secretes bioactive products like adipocytokines and microvesicles, which influence the cardiovascular system through both endocrine and paracrine effects. However, in states of obesity, inflammation and insulin resistance disrupt the function of adipose tissue, causing a shift in its secretions toward a pro-inflammatory and pro-atherogenic profile. This dysfunction contributes significantly to the development of cardiovascular diseases [7].
FTPP (Adipotide) shows potential as a treatment for heart disease by targeting and reducing unhealthy white adipose tissue. This helps decrease fat deposits, improve metabolism, lower inflammation, and reduce factors contributing to cardiovascular stress, offering a promising new approach to addressing root causes of heart disease.
Buy FTPP Adipotide Nasal Spray
Buy FTPP Adipotide nasal spray Monaco for clinical research purposes from Direct Sarms, available in 15ml and 30ml bottles.
Buy FTPP Adipotide Peptide Vial
Buy FTPP Adipotide Peptide Vial Monaco available in 2 mg and 10 mg vials for research use from Direct Sarms.
Does FTPP Adipotide have any side effects?
While research peptide FTPP (Adipotide) shows promise as a targeted treatment for obesity, it is important to be aware of potential side effects. Some Monaco studies have reported mild to moderate adverse effects, including fatigue, nausea, and dizziness. More serious side effects, such as kidney toxicity, have been observed in some preclinical studies, particularly with prolonged use or high dosages. Before starting any clinical research, it is crucial to consult a healthcare professional. This ensures the study aligns with the health needs of your test subjects and allows for proper monitoring of potential complications.
What makes FTPP Adipotide unique compared to other weight loss peptides?
It’s unique mechanism of targeting the blood vessels of white adipose tissue distinguishes it from traditional therapies, which often involve reducing appetite or increasing metabolism. By specifically disrupting the blood supply to fat cells, this targeted approach offers a novel pathway for managing obesity.
Is FTPP Adipotide safe for human use?
You can buy FTPP Adipotide for research only as its safety for human use has not been fully confirmed. Clinical trials and extensive testing are required to validate its efficacy and safety before it can be widely administered.
When will FTPP Adipotide be available for public use?
The exact timeline for Adipotide’s availability depends on the outcomes of ongoing research and clinical trials. Regulatory approvals from bodies such as the FDA will be necessary to ensure its safety and efficacy before it can be made commercially available. Only after meeting these stringent requirements will it be considered ready for public use.
What is the effect of FTPP Adipotide on fatty acid?
It works by targeting fatty acid transporters and cutting off the blood supply to fat cells (adipocytes), causing them to undergo programmed cell death (apoptosis). This helps with adipose tissue reduction and improves the transport and uptake of fatty acids. By breaking down stored fat more efficiently, it reduces overall fat levels and may also support better metabolic health. This unique mechanism makes Adipotide an innovative option for managing obesity compared to traditional methods.
Buy FTPP Adipotide Pre-Mixed Peptide 2mg Pen Monaco for in vitro and in vivo research laboratory purposes. The Pen Kit has everything you need: a pre-mixed cartridge with FTPP (Adipotide) 2mg and bacteriostatic water, a peptide cartridge pen with a carrying case, and three pen needle tips. Pre-mixed cartridges are also available to buy separately, and you can save 10% when you purchase three.
For more information, explore our latest blog posts dedicated to FTPP Adipotide peptide.
Buy FTPP Adipotide Monaco from Direct Sarms, your reliable source for 99% pure, research-grade peptides. Offered in a range of formats to suit your needs, including 2mg lyophilized powder vials, 15ml and 30ml nasal sprays, and convenient 2mg pre-mixed pens. Designed exclusively for laboratory research, this peptide delivers exceptional purity and quality, ensuring accurate and dependable results for your studies.
[1] Kirstin F Barnhart, Dawn R Christianson, Patrick W Hanley, Wouter H P Driessen, Bruce J Bernacky, et al (2011) A Peptidomimetic Targeting White Fat Causes Weight Loss and Improved Insulin Resistance in Obese Monkeys – Scientific Translational Medicine, 2011 Nov 9, Volume 3 (Issue 108), Page 108ra112.
[2] Dong-Hoon Kim, Stephen C Woods, and Randy J Seeley (2010) Peptide Designed to Elicit Apoptosis in Adipose Tissue Endothelium Reduces Food Intake and Body Weight – Diabetes, 2010 Jan 26, Volume 59 (Issue 4), Pages 907–915.
[3] Dong-Hoon Kim, Maureen A Sartor, James R Bain, Darleen Sandoval, Robert D Stevens, et al (2012) Rapid and weight-independent improvement of glucose tolerance induced by a peptide designed to elicit apoptosis in adipose tissue endothelium – Diabetes, 2012 Sep, Volume 61 (Issue 9), Pages 2299-310.
[4] Mikhail G Kolonin, Pradip K Saha, Lawrence Chan, Renata Pasqualini, and Wadih Arap (2004) Reversal of obesity by targeted ablation of adipose tissue – Nature Medicine, 2004 Jun, Volume 10 (Issue 6), Pages 625-32.
[5] Timon E Adolph, Christoph Grander, Felix Grabherr, and Herbert Tilg (2017) Adipokines and Non-Alcoholic Fatty Liver Disease: Multiple Interactions – International Journal of Molecular Sciences, 2017 Jul 29, Volume 18 (Issue 8), Page 1649.
[6] Fernanda I Staquicini 1, Marina Cardó-Vila, Mikhail G Kolonin, Martin Trepel, Julianna K Edwards, et al (2011) Vascular ligand-receptor mapping by direct combinatorial selection in cancer patients – Proceedings of the National Academy of Sciences of the United States of America, 2011 Nov 15, Volume 108 (Issue 46), Pages 18637-42.
[7] Evangelos K Oikonomou and Charalambos Antoniades (2019) The role of adipose tissue in cardiovascular health and disease – Nature Reviews: Cardiology, 2019 Feb, Volume 16 (Issue 2), Pages 83-99.
ALL CONTENT AND PRODUCT INFORMATION AVAILABLE ON THIS WEBSITE IS FOR EDUCATIONAL PURPOSES ONLY.
DISCLAIMER: These products are intended solely as a research chemical only. This classification allows for their use only for research development and laboratory studies. The information available on our Direct Sarms website is provided for educational purposes only. These products are not for human or animal use or consumption in any manner. Handling of these products should be limited to suitably qualified professionals. They are not to be classified as a drug, food, cosmetic, or medicinal product and must not be mislabelled or used as such.
Worldwide shipping
Visa/Mastercard/Zelle
Cryptocurrency /Transfers
Safe and Secure Shopping
We Distribute From
YOU MUST BE OVER 21 YEARS IN ORDER TO USE THIS WEBSITE. All of the products are to be handled only by properly trained and qualified LABORATORY or RESEARCH professionals.